2017 SPEAKERS:

 
 

 

Eric A Hughes, Development Unit Head, Immunology & Dermatology, Novartis

Marc Abromovitz, Head, Industrial Hygiene, Novartis

Dr Rafael Amado, Chief Medical Officer, Adaptimmune

Prof Steve Anderton, Chief Scientific Officer, Aquila BioMedical

Dr Sagrario Arias Rivas, Principal Scientist and Project Manager, Batavia Biosciences

Tudor Arvinte, President and Chief Executive Officer, Therapeomic Inc

Michael Avraam, Global Product Manager, ChargePoint Technology Ltd

Martin Axon, Principal, Occupational Hygienist of Operations for Europe, Safebridge

Philip Ball, Market Access Manager, Napp Pharmaceuticals

Fereshteh Barei, Health Economist, LEGOS Paris Dauphine University

Dr Roy Baynes, SVP of Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Karoline Bechtold Peters, Senior Strategy & Technology Leader - Pharmaceutical Development, F. Hoffmann-La Roche Ltd

Dr Alain Beck, Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Dr Alain Beck, Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Roger Beerli, CSO, NBE Therapeutics

Gary Bembridge, Senior Director Scientific Affairs – Immunology, Business Development, Abzena

Dr Ezio Bonvini, CSO, Macrogenics

Caroline Boulliat, Immunology, Oncology. Biosimilar Business Unit Head, Amgen Europe Gmbh

Dr Renier Brentjens, Director, Cellular Therapeutics, Memorial Sloan-Kettering Cancer Center

Dr Ulrich Brinkmann, Scientific Director, Expert Scientist, Roche

Joanna Brougher, Owner & Principal, BioPharma Law Group, PLLC, Biotech, Pharma and Medical Device IP and Corporate Co, BioPharma Law Group PLLC

Stefano Butti, Head of Sales Group, F.P.S. Food and Pharma Systems Srl

Martina Canestraro, Senior Research Scientist, Immunocore Ltd

Divya Chadha Manek, Head of Business Development (Commercial), National Institute for Health Research (NIHR)

Andre Choo, Principal Scientist and Director, Antibody Discovery, Bioprocessing Technology Institute

Dr Sarah Ciangerani, Head of the BioOrganic Mass Spectrometry Laboratory, CNRS UMR7178, University of Strasbourg

Dan Cimpoeru, Board Member, European Cancer Patient Coalition

Jeremy Clarke, Director of Commercial Development, Asterand Bioscience

Anne Cook, Biologicals Quality Assessor, M.H.R.A.

Nazanin Dadehbeigi, Principal Scientist, Fujifilm Diosynth Biotechnologies

Dr Jonathan Davis, Principal Scientist, Molecular Structure and Design, Bristol Myers Squibb

Lee Dawson, Senior Scientist, Molecular Pathology Group, Asterand Bioscience

Dr John Delaney, Executive Director, Amgen Biologics Discovery, Amgen

Dr Kangwen Deng, Senior Scientist, AbbVie

Dr Michael DeRidder, Senior Director, Early Pipeline Commercial Strategy for Oncology Cell Therapy, Neuroscience, and ADD, GSK

Margaret Dolan, Regional Pharmacy Procurement Specialist, N.H.S.

Dr Helena Domingues, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office

Dr Helena Domingues at World Biosimilar Congress

Prof Stefan Dübel, Director, Department of Biotechnology, Braunschweig University of Technology

Pieter Dylst, Senior Manager Market Access, Medicines for Europe

Dr Peter Ellmark, Principal Scientist, Immuno-oncology, Alligator Bioscience Ab

Dr Seth Ettenberg, Chief Scientific Officer, Unum Therapeutics Inc.

Catherine Evans, Business Development Manager for Biopharma, Bruker U.K. Ltd

Dr Joachim Feldwisch, Director of Preclinical Development, Affibody Ab

Dr Nicolas Fischer, Head for Research, Novimmune Sa

Mathias Flume, Head of Drug Department, Kassenarztliche Vereinigung Westfalen-Lippe

Francois Xavier Frapaise MD, CMO, Merck Biosimilars

Dr Jim Freeth, Managing Director, Retrogenix

Dr Jim Freeth, Managing Director, Retrogenix

Dr David Gilham, Vice President of Research and Development, Celyad

Ralf Gleixner, Head - Global Regulatory Affairs CMC, Merck

Jorge González Borroto, Pharmacovigilance Officer/Senior Toxicologist, Ferrer Internacional, S.A.

Dr Andrea Gonzalez-Munoz, Research Associate, Medimmune

Dr Ulf Grawunder, Chief Executive Officer & Founder, NBE Therapeutics

Uwe Gudat, Head of Safety, Biosimilars, Merck & Cie

Dr Guanghui Han, Scientific Manager, Genentech

Jatinder Harchowal, Jatinder Harchowal Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit, Royal Marsden NHS Foundation Trust

Dr Steffen Hartmann, Global Head Integrated Biologics Profiling, Novartis

Dr Haruki Hasegawa, Principal Scientist, Amgen

Professor Robert Hawkins, CEO and Co-founder, Cellular Therapeutics Ltd

Dr Peer Heine, Field Applications Scientist, Europe, MaxCyte

Helena Hemming, Senior Occupational Toxicologist, AstraZeneca

Ian Henshaw, Head of Business Operations, Biogen

Forrest Hu, General Manager of International Business, 3SBio Inc

Dr Yue Huang, Head of Clinical Pharmacology China, Merck

Dr Greta Hultqvist, Assistant Professor, Uppsala University

Ruediger Jankowsky, Managing Director, Cinfa Biotech

Dr Lutz Jermutus, Senior Director and Global Head of Technology, MedImmune Cambridge

Dr Lutz Jermutus at World Biosimilar Congress

Ulf Johansson, Project Manager, AstraZeneca

Dr Syd Johnson, Vice President of Antibody Engineering, Macrogenics

Dr Karin Jooss, Executive Vice President of Research, and Chief Scientific Officer, Gritstone Oncology

Peter Jorgensen, Chief Executive Officer, I.G.L.

Dr Milena Kalaitsidou, Post Doctoral Research Associate (University of Manchester), GSK

Michael Kalos, Chief Scientific Officer, Cancer Immunobiology, Eli Lilly and Co

Dr Sidath Katugampola, Biomarker Development Specialist, Cancer Research U.K. Cambridge Institute

Parminder Kaur, CEO, RegPak BioPharma Consulting

Dr Thomas Keating, Director of Biochemistry, Immunogen, Inc.

Alex Kelly, European Business Development Executive, Retrogenix

Tarek Kilani, Former Head of Pharmacy & Continuing Medical Education Coordinator, Emirates French Hospital Llc

Dr Christian Klein, Head Oncology Programs, Roche Pharmaceutical Research and Early Development

Dr Christian Kleusch, Application Specialist, NanoTemper

Martin Knight, Sr. Director, Strategy & Planning, Inflammation, Infectious Disease and General Medicine, Covance

Jenny Koppelkamm, Market Access Director, Takeda

Jenny Koppelkamm at World Biosimilar Congress

Dr Jiri Kovarik, Research Investigator, N.I.B.R.

Dr Carsten Kranz, Investigator III, Novartis

William Christopher Lamanna, Laboratory Head of Protein Characterization, Sandoz Inc

Dr Andreas Hougaard Laustsen, Postdoctoral Fellow, Technical University of Denmark

Olindo Lazzaro, Director, Environment, Health & Safety, AbbVie

Olindo Lazzaro at World Biosimilar Congress

Dr Marie-Paule LeFranc, Professor Emeritus, Universite De Montpellier

Dr James Legg, Vice President, Research and Development, Crescendo Biologics Ltd

Adam Levysohn, Head of Global Market Access Biogen Biosimilars Business Unit, Biogen

Patrick Liu, Vice President of Global Biologics R&D and Head of Biologics, Assays and Technology, Teva Pharmaceuticals U.S.A.

Ester Lovsin Barle, Head of Health Hazard Assessment Center of Excellence, Lonza

Ester Lovsin Barle at World Biosimilar Congress

Brian Lundstrom, Vice President of O.M.T. and C.B.O., Ligand Pharmaceuticals, Inc.

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Reinhold Maeck, Head of Corporation EH&S Regulatory Intelligence, Boeringer Ingelheim

Sara Martens, Senior Manager, OH/Containment, AbbVie

Márcia Martini Bueno, Institucional Affairs Director, Libbs Pharmaceutica Ltda

Dr Ivan Mascanfroni, Senior Scientist, Immunology Biologics, AbbVie

Justin Mason-Home, Director, HPAPI Services Limited

Steve McAleavy, Director, Ezi Dock Systems Ltd

Stewart McNaull, Senior VP, Business Development, KBI Biopharma

Dr Patrick Mehlen, Chief Executive Officer, Netris Pharma

Dr David Meininger, Chief Business Officer, Trianni Inc

Victor Lino Mendonça, VP Global Policy & Market Access Europe, Mylan

Dr Christoph Merten, Group Leader and Principal Investigator Genome Biology Unit, European Molecular Biology Laboratory

Vera Molkenthin, Chief Scientist, Abcheck s.r.o.

Dr M. Anthony Moody, Associate Professor of Paediatrics, Assistant Professor of Immunology, Duke University Medical Center

Carla Mouta-Bellum, , Finnegan Henderson Farabow Garrett and Dunner Llp

Dr Mostafa Nakach, Head of Pharmaceutical Engineering, Sanofi Aventis

Gopalan Narayanan, VP, Complex Bio, Voisin Consulting Life Sciences (VCLS)

Prof Dr Dario Neri, Co-founder, Philogen; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich

Cecil Nick, Vice President, PAREXEL

Rainer Nicolai, Technical Specialist, F. Hoffmann-La Roche Ltd

Dr Ahuva Nissim, Reader, William Harvey Research Institute

Dr Victor Obungu, Principal Research Scientist, Eli Lilly and Company

Dr Shane Olwill, Vice President of Development, Pieris Pharmaceuticals

Ber Oomen, Executive Secretary and Treasurer, ‎European Specialist Nurses Organisations

Mareike Ostertag, Director Regulatory and Science Policy, Novartis Pharma AG

Dr Angie Inkyung Park, Sr. Director of Immunotherapy and Stem Cells, Oncomed Pharmaceuticals

Dr Angie Inkyung Park at World Biosimilar Congress

Jeff Parry, Senior Scientist Manufacturability, AstraZeneca

Aurore Perzyna, Head of Production, Oril Industrie

Sari Pesonen, VP Scientific and Clinical Development, Co-Founder, Valo Therapeutics

Prof. Andreas Plueckthun, Professor of Biochemistry, Director, Department of Biochemistry, University of Zurich, Dept. of Biochemistry

Laurent Poirot, Head of Early Discovery, Cellectis

Sylvain Querol, European Technical and Tendering Manager, Powder Systems Limited (PSL)

Dr Alfonso Quintas, Head of Clinical Development, Cell Therapy, GSK

Dr Alfonso Quintas at World Biosimilar Congress

Dr Christoph Rader, Associate Professor, The Scripps Research Institute

Dr Alexey Rak, Head of Bio Structure and Biophysics, Sanofi

Dr Alexey Rak at World Biosimilar Congress

Dr Sai Reddy, Assistant Professor of Bimolecular Engineering, E.T.H. Zurich

Dr Janice Reichert, Executive Director, The Antibody Society

Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines

Dr Fabian Richter, Post-Doctoral Fellow, University of Stuttgart

Joaquin Rodrigo, Founder President, BIOSIM Spanish Association of Biosimilars

Dr Christian Rommel, Global Head of Oncology Discovery, F Hoffman La Roche Ltd

Dr Stacie Ropka, Partner, Axinn

Karsten Roth, Director Clinical Operations, Cinfa Biotech

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Dr Puja Sapra, Vice President and Chief Scientific Officer, Targeted Therapeutics Discovery, Oncology R&D, Pfizer Biotherapeutics

Dr Puja Sapra at World Biosimilar Congress

Dr Jose Saro, T.M.L. Pharma Research and Early Development, Oncology, Roche

Dr Volker Schellenberger, Chief Executive Officer & President, Amunix Inc

Joern Schmitz, Department Head, Fraunhofer I.M.E.

Dr Mike Schopperle, Chief Executive Officer, CureMeta Llc

Andreas Schreiner, Director of Validation, Manufacturing Science and Technology, Novartis Ag

Ingrid Schwarzenberger, Head of Global Regulatory Affairs Biopharmaceuticals, Sandoz Biopharmaceuticals Gmbh

Claudia Sehner, Principal Scientist Toxicology, Boehringer Ingelheim Pharma GmbH & Co. KG

Anjan Selz, Vice President – Head of Biosimilars EMEA, Lupin Europe Ltd

Dr Marjorie Shapiro, Chief of Laboratory of Molecular and Developmental Immunology, CDER, FDA

Tim Shea, Director, Sterne Kessler Goldstein And Fox Plc

Darko Skegro, Senior Investigator, Biotherapeutic and Analytical Technologies, Novartis Institutes for Biomedical Research

Jae Sly, Director of Strategic Business Development, ACRO Biosystems Inc

Jae Sly, Director of Strategic Business Development, ACRO Biosystems Inc

Dr James Smith, Research Associate, C.A.S.M.I. University of Oxford

Dr James Smith at World Biosimilar Congress

Shantreddy Soogareddy, Associate Director - External Development R&D (Alliance and Project management), Dr. Reddy's Laboratories Limited

Shantreddy Soogareddy at World Biosimilar Congress

Dr Oliver Spadiut, Group Leader of Integrated Bioprocess Development, Vienna University of Technology

Mark Spengler, Director, Project Management, Chimera Biotec GmbH

George Stefanov, Marketing Operations Director Biologics, Europe, Mylan

Don Stewart, President and Chief Executive Officer, PlantForm Corporation

Don Stewart at World Biosimilar Congress

Pawel Stocki, Senior Principal Scientist, Ossianix, Inc.

Dr Michael Streit, Sr Director Clinical Research Lead, Janssen

Marc Suter, Sr Sales Manager, Skan A.G.

Dr Martin Treder, Chief Scientific Officer, Affimed Therapeutics Ag

Dr Frédéric Triebel, Chief Scientific Officer and Medical Officer, Prima Biomed, Ltd

Gianluca Trifirò, Assistant Professor of Pharmacology, University of Messina

Anubhav Tripathi, Professor of Bioengineering and Medical Science, Brown University

Florian Turk, Head of Global Payor Marketing, Sales and Relations, Sandoz

Peter Ulrich, Safety Assessment Expert, Novartis Institutes for Biomedical Research

Jonathan Underhill, Associate Director for Medicines Evidence, NICE

Jonathan Underhill at World Biosimilar Congress

Dr Timo Van Den Berg, Professor of Immunotherapy, Head of Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory

Steve Vance, Senior Scientist, Crescendo Biologics Ltd

Dr Alain Vertes, Managing Director, NxR Biotechnologies

Dr Feng Wang, Principle Investigator, Biology, Calibr - California Institute for Biomedical Research

Silke Weber, Toxicology Project Lead, Roche

Dr Carl Webster, Principal Scientist, Antibody Discovery and Protein Engineering, MedImmune Cambridge

Manfred Weiler, Senior Vice President, Medical & Scientific Strategy, INC Research

Dr Martin Welschof, Chief Executive Officer, Opsona Therapeutics Ltd

Dr Andreas Wiesner, Global Product Manager Cell Culture Media, Sartorius Stedim Biotech U.K.

Sir Gregory Winter, Master, Trinity College Cambridge, University of Cambridge

Sir Gregory Winter, Master, Trinity College Cambridge, University of Cambridge

Robert Wojciechowski, Vice President, Global Regulatory Consulting, INC Research/inVentiv Health

Elena Wolff-Holz, Elena Wolff-Holz, Chair, Biosimilar Medicinal Products Working Party (BMWP), Paul Ehrlich Institut

Francis Wollerton, Director of Antibody Engineering, F-star Biotechnology Ltd

Jesper Worm, Scientist, CMC Biologics

Dr Jens Würthner, Head of Clinical Development – EU, ADC Therapeutics

René Wuttke, Bioanalytical Principal Investigator, Global Bioanalytical Services, Celerion Inc.

Jiannian Zhou, Director of Assay Development, ACRO Biosystems Inc

Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc